Search
Selected Filter
Displaying 1–10 of 193 research results
-
Horama Acquires Licensing Rights to CRB1 Gene Therapy
Company in France targets a clinical trial in 2023
-
10 Things to Know Before You Fall Victim to a Retinal Stem Cell Scam
An article by David Gamm, MD, PhD, a Foundation-funded researcher at the University of Wisconsin-Madison
-
First Patient Receives Emerging CRISPR Therapy in Clinical Trial for LCA 10
First time emerging CRISPR therapy administered inside the human body
-
ARVO 2014: LCA Gene Therapy Recipient Featured During Keynote
15-year-old Yannick Duwe transfixed the audience, describing how the treatment enabled him to use a computer instead of Braille, and work much easier and faster at school.
-
Researchers Report Six-Month Results from Biogen-Sponsored XLRP Gene Therapy Clinical Trial
Vision improvements observed with medium and high doses
-
Foundation Joins the Institute for Gene Therapies, a Newly Formed Advocacy Organization
IGT to accelerate gene therapy development and patient access
-
Genetic Testing for Inherited Retinal Diseases through the Foundation’s Open Access Program
The benefits of genetic testing for IRD patients, how to participate in the Foundation’s Open Access program, and what to expect from the genetic testing process.
-
AGTC Reports Positive Six-Month Results for XLRP Phase 1/2 Gene Therapy Trial
The company is planning a Phase 3, pivotal trial for end of 2020
-
First Human Study in US for Induced Pluripotent Stem Cells to be Launched for Advanced Dry AMD
Currently there are no treatments for Advanced Dry AMD, also known as GA, which can lead to significant central vision loss
-
First Patient Receives ProQR’s AON Therapy in Clinical Trial for RP Caused by RHO-P23H Mutation
The trial becomes ProQR’s third human study for inherited retinal disease therapies
